An introduction to the 2026 Oncology Nurse Advisor Summit and links to review the agenda and register to attend this year’s virtual event.

Researchers investigated the use of medication and medical services for mental health in women with invasive breast cancer, comparing use from 1 year before to 5 years after diagnosis.

Phase 3 trial data show datopotamab deruxtecan reduces the risk of disease progression or death in patients with metastatic TNBC.

HealthDay News — For the five leading causes of cancer-related death in people younger than 50 years, mortality decreased from 1990 through 2023, except for colorectal cancer (CRC), according to a ...

Researchers surveyed patients with blood cancer regarding what they value as the most important service in their hospice care.

Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for ...

In this phase 2 study, researchers explored whether fecal microbiota transplant could overcome resistance to immune checkpoint inhibition.

Investigators conducted this phase III trial to determine whether immunotherapy was more effective when administered early in the day.

The widespread use of standard laparoscopic procedures has been constrained by the technical difficulties presented by patients with PKD who have massively enlarged and cystic kidneys.

Zanzalintinib is an investigational oral agent that inhibits tyrosine kinase receptors associated with cancer growth, including TYRO3, VEGF, MET, AXL, and MER.

Researchers sought to measure the confidence healthcare providers and patients have regarding future use of large-language ...

An interim analysis of the prospective BIOPSTAGE trial determined optimal PET thresholds for SUVmax and SUVratio that ...